RE: Lilly, Novo Nordisk gird for diabetes drug ba.
Ya those two are going for it Al.
BYETTA sales last year were $650,000,000.00 . Expected to reach $1 Billion this year.
Liriglutide sales last year were $0.00. Expected to reach piddly squat levels of revenue in India this year.
And Novo's GLP1 Analogue STILL isn't approved. LOL!!
Glad to see that Byetta's Co. wants to take the next step in Diabetes care with Transitions Diabetes Platform.
Cheers